Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study
暂无分享,去创建一个
B. Monk | I. Vergote | M. Zikan | Susana Banerjee | E. Gort | D. Cibula | H. Denys | A. Westermann | E. Van Nieuwenhuysen | C. Mathews | D. Lorusso | K. Tewari | F. Köse | N. Ottevanger | D. Collins | R. O’Cearbhaill | S. Ghamande | C. Gennigens | A. Sadozye | F. Forget | A. Jackson | L. Randall | M. Chisamore | I. Soumaoro | Giovanni Scambia | L. Eaton | Kristine Madsen | C. Mondrup Andreassen | I. Boere | J. Baurain | Leonardo Viana Nicacio